Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Certara, Inc. (CERT) Guidance & Earnings Results

On 2026-08-04 Certara, Inc. reaffirmed guidance: "0% to 4% revenue…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CERTCertara, Inc.Follow CERT — free
Health Information Services · Healthcare
—
Price chart with a free account
Market cap
1.6B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
4 Aug 26Reaffirmed0% to 4% revenue growth · full year
11 May 26LoweredRevenue growth 0%-4% excluding divested business · full year
26 Feb 26ReaffirmedFY2026 revenue growth 0-4%; Adj. EBITDA margin 30-32%; Adj. diluted EPS $0.44-$0.48 · full year
6 Nov 25RaisedFull year 2025 revenue $415M-$420M; adjusted EBITDA margin ~32%; adjusted diluted EPS $0.45-$0.47 · full year
6 Aug 25ReaffirmedFY2025 revenue $415-425M; adjusted EBITDA margin 30-32%; adjusted diluted EPS $0.42-0.46; fully diluted shares 162-164M · full year

Certara, Inc. — questions

What guidance did Certara, Inc. give?
On 2026-08-04: "0% to 4% revenue growth"
When does Certara, Inc. report earnings?
Certara, Inc.'s next earnings report is expected on 2026-11-11.

Every figure on this page comes from Certara, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.